Financhill
Back

Protalix Biotherapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

PLX
Protalix Biotherapeutics, Inc.

Last Price:
$2.14
Seasonality Move:
7.54%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and PLX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Protalix Biotherapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.14 Buy
20-day SMA: 2.42 Sell
50-day SMA: 2.6 Sell
200-day SMA: 2.02 Buy
8-day EMA: 2.04 Buy
20-day EMA: 1.5 Buy
50-day EMA: 0.82 Buy
200-day EMA: 0.24 Buy

Protalix Biotherapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.56 Buy
Relative Strength Index (14 RSI): 37.44 Sell
Chaikin Money Flow: 845957 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.16 - 2.86) Sell
Bollinger Bands (100): (1.77 - 2.71) Sell

Protalix Biotherapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Protalix Biotherapeutics, Inc. Stock

Is Protalix Biotherapeutics, Inc. Stock a Buy?

PLX Technical Analysis vs Fundamental Analysis

Sell
30
Protalix Biotherapeutics, Inc. (PLX) is a Sell

Is Protalix Biotherapeutics, Inc. a Buy or a Sell?

Protalix Biotherapeutics, Inc. Stock Info

Market Cap:
169.3M
Price in USD:
2.15
Share Volume:
1.1M

Protalix Biotherapeutics, Inc. 52-Week Range

52-Week High:
3.19
52-Week Low:
1.32
Sell
30
Protalix Biotherapeutics, Inc. (PLX) is a Sell

Protalix Biotherapeutics, Inc. Share Price Forecast

Is Protalix Biotherapeutics, Inc. Stock a Buy?

Technical Analysis of Protalix Biotherapeutics, Inc.

Should I short Protalix Biotherapeutics, Inc. stock?

* Protalix Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.